report cover

Immune Cell Therapy Drugs Market, Global Outlook and Forecast 2022-2028

  • 15 April 2022
  • Life Sciences
  • 65 Pages
  • Report code : 24WT-7000753

Immune Cell Therapy Drugs and Forecast Market

1 Introduction to Research & Analysis Reports
1.1 Immune Cell Therapy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immune Cell Therapy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immune Cell Therapy Drugs Overall Market Size
2.1 Global Immune Cell Therapy Drugs Market Size: 2021 VS 2028
2.2 Global Immune Cell Therapy Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immune Cell Therapy Drugs Players in Global Market
3.2 Top Global Immune Cell Therapy Drugs Companies Ranked by Revenue
3.3 Global Immune Cell Therapy Drugs Revenue by Companies
3.4 Top 3 and Top 5 Immune Cell Therapy Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Immune Cell Therapy Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immune Cell Therapy Drugs Players in Global Market
3.6.1 List of Global Tier 1 Immune Cell Therapy Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Immune Cell Therapy Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Immune Cell Therapy Drugs Market Size Markets, 2021 & 2028
4.1.2 Monoclonal Antibodies
4.1.3 Immunomodulator
4.1.4 Other
4.2 By Type - Global Immune Cell Therapy Drugs Revenue & Forecasts
4.2.1 By Type - Global Immune Cell Therapy Drugs Revenue, 2017-2022
4.2.2 By Type - Global Immune Cell Therapy Drugs Revenue, 2023-2028
4.2.3 By Type - Global Immune Cell Therapy Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immune Cell Therapy Drugs Market Size, 2021 & 2028
5.1.2 Stomach Cancer
5.1.3 lung Cancer
5.1.4 Colorectal Cancer
5.1.5 Esophageal Cancer
5.1.6 Pancreatic Cancer
5.1.7 Other
5.2 By Application - Global Immune Cell Therapy Drugs Revenue & Forecasts
5.2.1 By Application - Global Immune Cell Therapy Drugs Revenue, 2017-2022
5.2.2 By Application - Global Immune Cell Therapy Drugs Revenue, 2023-2028
5.2.3 By Application - Global Immune Cell Therapy Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Immune Cell Therapy Drugs Market Size, 2021 & 2028
6.2 By Region - Global Immune Cell Therapy Drugs Revenue & Forecasts
6.2.1 By Region - Global Immune Cell Therapy Drugs Revenue, 2017-2022
6.2.2 By Region - Global Immune Cell Therapy Drugs Revenue, 2023-2028
6.2.3 By Region - Global Immune Cell Therapy Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Immune Cell Therapy Drugs Revenue, 2017-2028
6.3.2 US Immune Cell Therapy Drugs Market Size, 2017-2028
6.3.3 Canada Immune Cell Therapy Drugs Market Size, 2017-2028
6.3.4 Mexico Immune Cell Therapy Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Immune Cell Therapy Drugs Revenue, 2017-2028
6.4.2 Germany Immune Cell Therapy Drugs Market Size, 2017-2028
6.4.3 France Immune Cell Therapy Drugs Market Size, 2017-2028
6.4.4 U.K. Immune Cell Therapy Drugs Market Size, 2017-2028
6.4.5 Italy Immune Cell Therapy Drugs Market Size, 2017-2028
6.4.6 Russia Immune Cell Therapy Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Immune Cell Therapy Drugs Market Size, 2017-2028
6.4.8 Benelux Immune Cell Therapy Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Immune Cell Therapy Drugs Revenue, 2017-2028
6.5.2 China Immune Cell Therapy Drugs Market Size, 2017-2028
6.5.3 Japan Immune Cell Therapy Drugs Market Size, 2017-2028
6.5.4 South Korea Immune Cell Therapy Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Immune Cell Therapy Drugs Market Size, 2017-2028
6.5.6 India Immune Cell Therapy Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Immune Cell Therapy Drugs Revenue, 2017-2028
6.6.2 Brazil Immune Cell Therapy Drugs Market Size, 2017-2028
6.6.3 Argentina Immune Cell Therapy Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immune Cell Therapy Drugs Revenue, 2017-2028
6.7.2 Turkey Immune Cell Therapy Drugs Market Size, 2017-2028
6.7.3 Israel Immune Cell Therapy Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Immune Cell Therapy Drugs Market Size, 2017-2028
6.7.5 UAE Immune Cell Therapy Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Aquila BioMedical
7.1.1 Aquila BioMedical Corporate Summary
7.1.2 Aquila BioMedical Business Overview
7.1.3 Aquila BioMedical Immune Cell Therapy Drugs Major Product Offerings
7.1.4 Aquila BioMedical Immune Cell Therapy Drugs Revenue in Global Market (2017-2022)
7.1.5 Aquila BioMedical Key News
7.2 BPS Bioscience
7.2.1 BPS Bioscience Corporate Summary
7.2.2 BPS Bioscience Business Overview
7.2.3 BPS Bioscience Immune Cell Therapy Drugs Major Product Offerings
7.2.4 BPS Bioscience Immune Cell Therapy Drugs Revenue in Global Market (2017-2022)
7.2.5 BPS Bioscience Key News
7.3 Celentyx
7.3.1 Celentyx Corporate Summary
7.3.2 Celentyx Business Overview
7.3.3 Celentyx Immune Cell Therapy Drugs Major Product Offerings
7.3.4 Celentyx Immune Cell Therapy Drugs Revenue in Global Market (2017-2022)
7.3.5 Celentyx Key News
7.4 Crown Bioscience
7.4.1 Crown Bioscience Corporate Summary
7.4.2 Crown Bioscience Business Overview
7.4.3 Crown Bioscience Immune Cell Therapy Drugs Major Product Offerings
7.4.4 Crown Bioscience Immune Cell Therapy Drugs Revenue in Global Market (2017-2022)
7.4.5 Crown Bioscience Key News
7.5 DiscoverX Corporation
7.5.1 DiscoverX Corporation Corporate Summary
7.5.2 DiscoverX Corporation Business Overview
7.5.3 DiscoverX Corporation Immune Cell Therapy Drugs Major Product Offerings
7.5.4 DiscoverX Corporation Immune Cell Therapy Drugs Revenue in Global Market (2017-2022)
7.5.5 DiscoverX Corporation Key News
7.6 Explicyte
7.6.1 Explicyte Corporate Summary
7.6.2 Explicyte Business Overview
7.6.3 Explicyte Immune Cell Therapy Drugs Major Product Offerings
7.6.4 Explicyte Immune Cell Therapy Drugs Revenue in Global Market (2017-2022)
7.6.5 Explicyte Key News
7.7 Genscript Biotech Corporation
7.7.1 Genscript Biotech Corporation Corporate Summary
7.7.2 Genscript Biotech Corporation Business Overview
7.7.3 Genscript Biotech Corporation Immune Cell Therapy Drugs Major Product Offerings
7.7.4 Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue in Global Market (2017-2022)
7.7.5 Genscript Biotech Corporation Key News
7.8 HD Biosciences
7.8.1 HD Biosciences Corporate Summary
7.8.2 HD Biosciences Business Overview
7.8.3 HD Biosciences Immune Cell Therapy Drugs Major Product Offerings
7.8.4 HD Biosciences Immune Cell Therapy Drugs Revenue in Global Market (2017-2022)
7.8.5 HD Biosciences Key News
7.9 Horizon Discovery Group
7.9.1 Horizon Discovery Group Corporate Summary
7.9.2 Horizon Discovery Group Business Overview
7.9.3 Horizon Discovery Group Immune Cell Therapy Drugs Major Product Offerings
7.9.4 Horizon Discovery Group Immune Cell Therapy Drugs Revenue in Global Market (2017-2022)
7.9.5 Horizon Discovery Group Key News
7.10 ImmunXperts
7.10.1 ImmunXperts Corporate Summary
7.10.2 ImmunXperts Business Overview
7.10.3 ImmunXperts Immune Cell Therapy Drugs Major Product Offerings
7.10.4 ImmunXperts Immune Cell Therapy Drugs Revenue in Global Market (2017-2022)
7.10.5 ImmunXperts Key News
7.11 Molecular Imaging
7.11.1 Molecular Imaging Corporate Summary
7.11.2 Molecular Imaging Business Overview
7.11.3 Molecular Imaging Immune Cell Therapy Drugs Major Product Offerings
7.11.4 Molecular Imaging Immune Cell Therapy Drugs Revenue in Global Market (2017-2022)
7.11.5 Molecular Imaging Key News
7.12 Promega Corporation,Personalis
7.12.1 Promega Corporation,Personalis Corporate Summary
7.12.2 Promega Corporation,Personalis Business Overview
7.12.3 Promega Corporation,Personalis Immune Cell Therapy Drugs Major Product Offerings
7.12.4 Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue in Global Market (2017-2022)
7.12.5 Promega Corporation,Personalis Key News
7.13 STC Biologics
7.13.1 STC Biologics Corporate Summary
7.13.2 STC Biologics Business Overview
7.13.3 STC Biologics Immune Cell Therapy Drugs Major Product Offerings
7.13.4 STC Biologics Immune Cell Therapy Drugs Revenue in Global Market (2017-2022)
7.13.5 STC Biologics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Immune Cell Therapy Drugs Market Opportunities & Trends in Global Market
Table 2. Immune Cell Therapy Drugs Market Drivers in Global Market
Table 3. Immune Cell Therapy Drugs Market Restraints in Global Market
Table 4. Key Players of Immune Cell Therapy Drugs in Global Market
Table 5. Top Immune Cell Therapy Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Immune Cell Therapy Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Immune Cell Therapy Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Immune Cell Therapy Drugs Product Type
Table 9. List of Global Tier 1 Immune Cell Therapy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immune Cell Therapy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Immune Cell Therapy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Immune Cell Therapy Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Immune Cell Therapy Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Immune Cell Therapy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Immune Cell Therapy Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Immune Cell Therapy Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Immune Cell Therapy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Immune Cell Therapy Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Immune Cell Therapy Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Immune Cell Therapy Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Immune Cell Therapy Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Immune Cell Therapy Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Immune Cell Therapy Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Immune Cell Therapy Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Aquila BioMedical Corporate Summary
Table 31. Aquila BioMedical Immune Cell Therapy Drugs Product Offerings
Table 32. Aquila BioMedical Immune Cell Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 33. BPS Bioscience Corporate Summary
Table 34. BPS Bioscience Immune Cell Therapy Drugs Product Offerings
Table 35. BPS Bioscience Immune Cell Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Celentyx Corporate Summary
Table 37. Celentyx Immune Cell Therapy Drugs Product Offerings
Table 38. Celentyx Immune Cell Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Crown Bioscience Corporate Summary
Table 40. Crown Bioscience Immune Cell Therapy Drugs Product Offerings
Table 41. Crown Bioscience Immune Cell Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 42. DiscoverX Corporation Corporate Summary
Table 43. DiscoverX Corporation Immune Cell Therapy Drugs Product Offerings
Table 44. DiscoverX Corporation Immune Cell Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Explicyte Corporate Summary
Table 46. Explicyte Immune Cell Therapy Drugs Product Offerings
Table 47. Explicyte Immune Cell Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Genscript Biotech Corporation Corporate Summary
Table 49. Genscript Biotech Corporation Immune Cell Therapy Drugs Product Offerings
Table 50. Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 51. HD Biosciences Corporate Summary
Table 52. HD Biosciences Immune Cell Therapy Drugs Product Offerings
Table 53. HD Biosciences Immune Cell Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Horizon Discovery Group Corporate Summary
Table 55. Horizon Discovery Group Immune Cell Therapy Drugs Product Offerings
Table 56. Horizon Discovery Group Immune Cell Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 57. ImmunXperts Corporate Summary
Table 58. ImmunXperts Immune Cell Therapy Drugs Product Offerings
Table 59. ImmunXperts Immune Cell Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Molecular Imaging Corporate Summary
Table 61. Molecular Imaging Immune Cell Therapy Drugs Product Offerings
Table 62. Molecular Imaging Immune Cell Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Promega Corporation,Personalis Corporate Summary
Table 64. Promega Corporation,Personalis Immune Cell Therapy Drugs Product Offerings
Table 65. Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue (US$, Mn), (2017-2022)
Table 66. STC Biologics Corporate Summary
Table 67. STC Biologics Immune Cell Therapy Drugs Product Offerings
Table 68. STC Biologics Immune Cell Therapy Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Immune Cell Therapy Drugs Segment by Type in 2021
Figure 2. Immune Cell Therapy Drugs Segment by Application in 2021
Figure 3. Global Immune Cell Therapy Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Immune Cell Therapy Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Immune Cell Therapy Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immune Cell Therapy Drugs Revenue in 2021
Figure 8. By Type - Global Immune Cell Therapy Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Immune Cell Therapy Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Immune Cell Therapy Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Immune Cell Therapy Drugs Revenue Market Share, 2017-2028
Figure 12. US Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Immune Cell Therapy Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Immune Cell Therapy Drugs Revenue Market Share, 2017-2028
Figure 24. China Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Immune Cell Therapy Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Immune Cell Therapy Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Immune Cell Therapy Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Aquila BioMedical Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BPS Bioscience Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Celentyx Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Crown Bioscience Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. DiscoverX Corporation Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Explicyte Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. HD Biosciences Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Horizon Discovery Group Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. ImmunXperts Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Molecular Imaging Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. STC Biologics Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Immune Cell Therapy Drugs and Forecast Market

Leave This Empty: